<!doctype html><html lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=robots content="noodp"><meta http-equiv=x-ua-compatible content="IE=edge, chrome=1"><title>Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding - Los los los</title><meta name=description content="In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><meta property="og:title" content="Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><meta property="og:description" content="In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><meta property="og:type" content="article"><meta property="og:url" content="https://sosiristseng.github.io/posts/paper/ellinwood-2017/"><meta property="og:image" content="https://sosiristseng.github.io/"><meta property="article:published_time" content="2020-10-22T23:52:20+08:00"><meta property="article:modified_time" content="2021-01-12T17:27:45+08:00"><meta name=twitter:card content="summary_large_image"><meta name=twitter:image content="https://sosiristseng.github.io/"><meta name=twitter:title content="Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><meta name=twitter:description content="In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><meta name=application-name content="Los los los"><meta name=apple-mobile-web-app-title content="Los los los"><meta name=theme-color content="#ffffff"><meta name=msapplication-TileColor content="#da532c"><link rel=icon href=parrot.svg><link rel=apple-touch-icon sizes=180x180 href=/apple-touch-icon.png><link rel=mask-icon href=/safari-pinned-tab.svg color=#5bbad5><link rel=manifest href=/site.webmanifest><link rel=canonical href=https://sosiristseng.github.io/posts/paper/ellinwood-2017/><link rel=prev href=https://sosiristseng.github.io/posts/paper/deoliveira-2016/><link rel=next href=https://sosiristseng.github.io/posts/paper/felmlee-2013/><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/normalize.css@8.0.1/normalize.min.css><link rel=stylesheet href=/css/style.min.css><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5.13.0/css/all.min.css><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/animate.css@3.7.2/animate.min.css><script type=application/ld+json>{"@context":"http://schema.org","@type":"BlogPosting","headline":"Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding","inLanguage":"en","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/sosiristseng.github.io\/posts\/paper\/ellinwood-2017\/"},"genre":"posts","keywords":"ODE","wordcount":810,"url":"https:\/\/sosiristseng.github.io\/posts\/paper\/ellinwood-2017\/","datePublished":"2020-10-22T23:52:20+08:00","dateModified":"2021-01-12T17:27:45+08:00","license":"This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.","publisher":{"@type":"Organization","name":"xxxx"},"author":{"@type":"Person","name":"Ellinwood et al."},"description":"In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"}</script></head><body header-desktop=fixed header-mobile=auto><script type=text/javascript>(window.localStorage&&localStorage.getItem('theme')?localStorage.getItem('theme')==='dark':('auto'==='auto'?window.matchMedia('(prefers-color-scheme: dark)').matches:'auto'==='dark'))&&document.body.setAttribute('theme','dark');</script><div id=mask></div><div class=wrapper><header class=desktop id=header-desktop><div class=header-wrapper><div class=header-title><a href=/ title="Los los los"><span class=header-title-pre><i class="fas fa-crow fa-fw"></i></span>Los los los</a></div><div class=menu><div class=menu-inner><a class=menu-item href=/posts/ title=Posts>Posts </a><a class=menu-item href=/categories/reading/ title="Paper reading">Reading </a><a class=menu-item href=/tags/ title=Tags>Tags </a><a class=menu-item href=/categories/ title=Categories>Categories </a><a class=menu-item href=/about/ title="About Me">About Me </a><a class=menu-item href=https://github.com/sosiristseng/ title=GitHub rel="noopener noreferrer" target=_blank><i class="fab fa-github-alt fa-fw"></i></a><span class="menu-item delimiter"></span><span class="menu-item search" id=search-desktop><input type=text placeholder=Search id=search-input-desktop>
<a href=javascript:void(0); class="search-button search-toggle" id=search-toggle-desktop title=Search><i class="fas fa-search fa-fw"></i></a><a href=javascript:void(0); class="search-button search-clear" id=search-clear-desktop title=Clear><i class="fas fa-times-circle fa-fw"></i></a><span class="search-button search-loading" id=search-loading-desktop><i class="fas fa-spinner fa-fw fa-spin"></i></span></span><a href=javascript:void(0); class="menu-item theme-switch" title="Switch Theme"><i class="fas fa-adjust fa-fw"></i></a></div></div></div></header><header class=mobile id=header-mobile><div class=header-container><div class=header-wrapper><div class=header-title><a href=/ title="Los los los"><span class=header-title-pre><i class="fas fa-crow fa-fw"></i></span>Los los los</a></div><div class=menu-toggle id=menu-toggle-mobile><span></span><span></span><span></span></div></div><div class=menu id=menu-mobile><div class=search-wrapper><div class="search mobile" id=search-mobile><input type=text placeholder=Search id=search-input-mobile>
<a href=javascript:void(0); class="search-button search-toggle" id=search-toggle-mobile title=Search><i class="fas fa-search fa-fw"></i></a><a href=javascript:void(0); class="search-button search-clear" id=search-clear-mobile title=Clear><i class="fas fa-times-circle fa-fw"></i></a><span class="search-button search-loading" id=search-loading-mobile><i class="fas fa-spinner fa-fw fa-spin"></i></span></div><a href=javascript:void(0); class=search-cancel id=search-cancel-mobile>Cancel</a></div><a class=menu-item href=/posts/ title=Posts>Posts</a><a class=menu-item href=/categories/reading/ title="Paper reading">Reading</a><a class=menu-item href=/tags/ title=Tags>Tags</a><a class=menu-item href=/categories/ title=Categories>Categories</a><a class=menu-item href=/about/ title="About Me">About Me</a><a class=menu-item href=https://github.com/sosiristseng/ title=GitHub rel="noopener noreferrer" target=_blank><i class="fab fa-github-alt fa-fw"></i></a><a href=javascript:void(0); class="menu-item theme-switch" title="Switch Theme">
<i class="fas fa-adjust fa-fw"></i></a></div></div></header><div class="search-dropdown desktop"><div id=search-dropdown-desktop></div></div><div class="search-dropdown mobile"><div id=search-dropdown-mobile></div></div><main class=main><div class=container><div class=toc id=toc-auto><h2 class=toc-title>Contents</h2><div class=toc-content id=toc-content-auto></div></div><article class="page single"><h1 class="single-title animated flipInX">Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding</h1><div class=post-meta><div class=post-meta-line><span class=post-author><a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681918/ title=Author target=_blank rel="noopener noreferrer author" class=author><i class="fas fa-user-circle fa-fw"></i>Ellinwood et al.</a></span>&nbsp;<span class=post-category>included in <a href=/categories/reading/><i class="far fa-folder fa-fw"></i>Reading</a>&nbsp;<a href=/categories/cardiomyocyte/><i class="far fa-folder fa-fw"></i>Cardiomyocyte</a></span></div><div class=post-meta-line><i class="far fa-calendar-alt fa-fw"></i>&nbsp;<time datetime=2020-10-22>2020-10-22</time>&nbsp;<i class="fas fa-pencil-alt fa-fw"></i>&nbsp;810 words&nbsp;
<i class="far fa-clock fa-fw"></i>&nbsp;4 minutes&nbsp;</div></div><div class="details toc" id=toc-static kept><div class="details-summary toc-title"><span>Contents</span>
<span><i class="details-icon fas fa-angle-right"></i></span></div><div class="details-content toc-content" id=toc-content-static><nav id=TableOfContents><ul><li><a href=#introduction>Introduction</a></li><li><a href=#methods>Methods</a><ul><li><a href=#atrial-ap-model-and-simulationss>Atrial AP Model and Simulationss</a></li><li><a href=#kv15-drug-binding-model>KV1.5 Drug-Binding Model</a></li></ul></li><li><a href=#results>Results</a><ul><li><a href=#role-of-ikur-in-nsr-and-caf-atrial-electrophysiology>Role of IKur in nSR and cAF Atrial Electrophysiology</a></li><li><a href=#effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-apd-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte APD at Normal and Fast Pacing Rates in cAF Conditions</a></li><li><a href=#effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-erp-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte ERP at Normal and Fast Pacing Rates in cAF Conditions</a></li><li><a href=#effects-of-drug-bindingunbinding-kinetics-with-variable-kd-on-apd-erp-and-ca2-handling>Effects of Drug Binding/Unbinding Kinetics with Variable Kd on APD, ERP, and Ca2+ Handling</a></li><li><a href=#effect-of-relative-state-specific-drug-binding>Effect of Relative State-Specific Drug Binding</a></li></ul></li><li><a href=#discussion>Discussion</a><ul><li><a href=#ikur-role-in-apd-and-erp-regulation-is-preserved-despite-its-downregulation-in-caf>IKur Role in APD and ERP Regulation Is Preserved Despite Its Downregulation in cAF</a></li></ul></li></ul></nav></div></div><div class=content id=content><p><a href=https://sciwheel.com/work/#/items/6117352 target=_blank rel="noopener noreferrer">Sciwheel</a></p><h2 id=introduction>Introduction</h2><ul><li>Atrial fibrillation (AF) is characterized by rapid, irregular heart contractions following fast, disorganized electrical signals in the atria</li><li>most common cardiac arrhythmia (1-2%)</li><li>Pharmacological therapy against AF is limited by low efficacy and substantial adverse side effects including an increased risk of lethal ventricular tachyarrhythmias. radiofrequency ablation is the most effective treatment.</li><li>Genetic mutations causing both loss- and gain-of-function of <strong>IKur</strong> have been associated with atrial arrhythmias in human</li></ul><h2 id=methods>Methods</h2><h3 id=atrial-ap-model-and-simulationss>Atrial AP Model and Simulationss</h3><ul><li>Grandi et al. model</li><li>IKur gating was described by a 6-state Markov type model</li><li>The cycle length (CL) was allowed to vary randomly following a uniform distribution between 285.7 and 400 ms, corresponding to a minimum pacing frequency of 2.5 Hz and a maximum pacing frequency of 3.5 Hz</li><li>The model code is available for download at the following webpages: <a href=https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/>https://somapp.ucdmc.ucdavis.edu/Pharmacology/bers/</a> and <a href=http://elegrandi.wixsite.com/grandilab/downloads>http://elegrandi.wixsite.com/grandilab/downloads</a> (e-mail required)</li><li>Parameter sensitivity analysis was performed with the population-based approach described in Sobie (2009), Morotti et al. (2017), and Morotti and Grandi (2017)</li></ul><h3 id=kv15-drug-binding-model>KV1.5 Drug-Binding Model</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg></p><ul><li>dissociation constants (Kd) for our drug scenarios were calculated as koff/kon, and affinity constants were calculated as kon/koff</li></ul><h2 id=results>Results</h2><h3 id=role-of-ikur-in-nsr-and-caf-atrial-electrophysiology>Role of IKur in nSR and cAF Atrial Electrophysiology</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g001.jpg></p><ul><li>900 variations of our nSR (normal sinus rhythm) and cAF (chronic AF) human atrial cardiomyocyte models</li><li>At 3-Hz pacing, GKur impacts AP and ERP prolongation more in cAF vs. nSR despite the fact that GKur is smaller in cAF conditions.</li><li>This points to IKur inhibition as a promising approach to counteract the abbreviated APD and ERP in cAF</li></ul><h3 id=effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-apd-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte APD at Normal and Fast Pacing Rates in cAF Conditions</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g002.jpg></p><ul><li>both types of inhibitors display a biphasic relationship between APD and drug-binding kinetics at 1- and 3-Hz pacing</li><li>Significant APD prolongation is only seen for intermediate drug-binding kinetics (0.3â€“30 sâˆ’1 for the open state blocker and 1â€“30 sâˆ’1 for the open and inactivated state blocker)</li><li>At 3-Hz pacing, the two types of inhibitors cause stronger relative prolongation as compared to 1-Hz pacing</li></ul><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g003.jpg></p><ul><li>Results in drug-free conditions and for an O & I blocker (modeled as in Figure 2F, black) with kon = koff (Kd = 1 Î¼M) in Figure 3 again demonstrate a biphasic relationship between drug-binding kinetics and average APD90</li></ul><h3 id=effect-of-conformational-state-specificity-and-bindingunbinding-kinetics-on-human-atrial-cardiomyocyte-erp-at-normal-and-fast-pacing-rates-in-caf-conditions>Effect of Conformational State Specificity and Binding/Unbinding Kinetics on Human Atrial Cardiomyocyte ERP at Normal and Fast Pacing Rates in cAF Conditions</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g004.jpg></p><ul><li>The desired effect of IKur inhibitors is prolongation of atrial ERP (effective refractory peroid)</li><li>Simulations reveal a similar biphasic relationship between ERP and drug-binding kinetics</li><li>At 1-Hz pacing, IKur inhibitors cause minimal ERP prolongation at slow drug-binding rates (â‰¤0.3 Hz) and fast drug-binding rates (100 Hz)</li><li>ERP prolongation remains ~62 ms lower than the ERP in nSR given no block of IKur for both inhibitors</li><li>At 3-Hz pacing, however, IKur inhibitors appear to be more effective at extending ERP than APD => favorable drug property</li></ul><h3 id=effects-of-drug-bindingunbinding-kinetics-with-variable-kd-on-apd-erp-and-ca2-handling>Effects of Drug Binding/Unbinding Kinetics with Variable Kd on APD, ERP, and Ca2+ Handling</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g005.jpg></p><ul><li>Previous figure are for k_on = k_off (Kd = 1)</li><li>Here we simulated all permutations of the nine different rates of drug binding (0.01 to 100 sâˆ’1), yielding 81 different combinations of kon and koff for the O & I state inhibitors</li><li>Except for the drugs with the largest Kd values (koff &#187; kon), when kon is held constant, APD, ERP, and Ca2+ handling are not very sensitive to changes in koff. the effects of IKur inhibitors on atrial electrophysiology and Ca2+ handling are largely driven by kon rates as compared to koff rates.</li><li>In cAF conditions, ideal IKur inhibitors exhibiting AF-selectivity will prolong atrial refractoriness (ERP prolongation at 3-Hz pacing), have limited toxicity (minimal to no APD prolongation at 1-Hz pacing), and have a positive inotropic effect (an increase in CaTamp at 1-Hz pacing)</li></ul><h3 id=effect-of-relative-state-specific-drug-binding>Effect of Relative State-Specific Drug Binding</h3><p><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g006.jpg></p><h2 id=discussion>Discussion</h2><ul><li>we sought to determine if IKur is a suitable anti-AF target despite it being downregulated in cAF patients</li><li>we implemented an in silico assessment of IKur inhibitors in cAF atrial cardiomyocyte models, and identified metrics for delineating ideal KV1.5 blockers against AF</li></ul><p><figure><a class=lightgallery href=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg title=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg data-thumbnail=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg data-sub-html="<h2>Summary of main findings</h2>"><img class=lazyload src=/svg/loading.min.svg data-src=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg data-srcset="https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg 1.5x, https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg 2x" data-sizes=auto alt=https://www.frontiersin.org/files/Articles/301424/fphar-08-00799-HTML/image_m/fphar-08-00799-g007.jpg></a><figcaption class=image-caption>Summary of main findings</figcaption></figure></p><ul><li>Our simulations suggest that electrophysiological properties in cAF cardiomyocytes, such as shorter AP and more depolarized plateau potential, both might act to increase efficacy and dampen cardiotoxicity of potential KV1.5-targeting drugs as compared to nSR</li></ul><h3 id=ikur-role-in-apd-and-erp-regulation-is-preserved-despite-its-downregulation-in-caf>IKur Role in APD and ERP Regulation Is Preserved Despite Its Downregulation in cAF</h3><ul><li>the consequences of IKur inhibition, including the extent of AP and ERP prolongation, depend not only on IKur magnitude (i.e., maximal conductance), but also on other fluxes affected by AF-induced remodeling</li><li>APD90 and ERP are more sensitive to changes in GKur at fast vs. slow pacing rates</li><li>GKur impacted the duration of AP repolarization and refractoriness more in cAF vs. nSR</li><li>Enhanced Efficacy and Safety of IKur Inhibitors in cAF vs. nSR</li></ul></div><div class=post-footer id=post-footer><div class=post-info><div class=post-info-line><div class=post-info-mod><span>Updated on 2021-01-12&nbsp;<a class=git-hash href=https://github.com/sosiristseng/sosiristseng.github.io/commit/ec3b7a2ee1e451157a735faf50670cddf4b2b5d2 target=_blank rel="noopener noreferrer" title="commit by Wen-Wei Tseng(sosiristseng@gmail.com) ec3b7a2ee1e451157a735faf50670cddf4b2b5d2: Format reading notes">
<i class="fas fa-hashtag fa-fw"></i>ec3b7a2</a></span></div><div class=post-info-license></div></div><div class=post-info-line><div class=post-info-md><span><a class=link-to-markdown href=/posts/paper/ellinwood-2017/index.md target=_blank rel="noopener noreferrer">Read Markdown</a></span></div><div class=post-info-share><span><a href=javascript:void(0); title="Share on Twitter" data-sharer=twitter data-url=https://sosiristseng.github.io/posts/paper/ellinwood-2017/ data-title="Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding" data-via=sosiristseng data-hashtags=ODE><i class="fab fa-twitter fa-fw"></i></a><a href=javascript:void(0); title="Share on Facebook" data-sharer=facebook data-url=https://sosiristseng.github.io/posts/paper/ellinwood-2017/ data-hashtag=ODE><i class="fab fa-facebook-square fa-fw"></i></a><a href=javascript:void(0); title="Share on Hacker News" data-sharer=hackernews data-url=https://sosiristseng.github.io/posts/paper/ellinwood-2017/ data-title="Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><i class="fab fa-hacker-news fa-fw"></i></a><a href=javascript:void(0); title="Share on Reddit" data-sharer=reddit data-url=https://sosiristseng.github.io/posts/paper/ellinwood-2017/><i class="fab fa-reddit fa-fw"></i></a><a href=javascript:void(0); title="Share on Line" data-sharer=line data-url=https://sosiristseng.github.io/posts/paper/ellinwood-2017/ data-title="Ellinwood 2017 | In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding"><i data-svg-src=https://cdn.jsdelivr.net/npm/simple-icons@2.14.0/icons/line.svg></i></a></span></div></div></div><div class=post-info-more><section class=post-tags><i class="fas fa-tags fa-fw"></i>&nbsp;<a href=/tags/ode/>ODE</a></section><section><span><a href=javascript:void(0); onclick=window.history.back();>Back</a></span>&nbsp;|&nbsp;<span><a href=/>Home</a></span></section></div><div class=post-nav><a href=/posts/paper/deoliveira-2016/ class=prev rel=prev title="Deoliveira 2016 | A biophysical systems approach to identifying the pathways of acute and chronic doxorubicin mitochondrial cardiotoxicity"><i class="fas fa-angle-left fa-fw"></i>Deoliveira 2016 | A biophysical systems approach to identifying the pathways of acute and chronic doxorubicin mitochondrial cardiotoxicity</a>
<a href=/posts/paper/felmlee-2013/ class=next rel=next title="Felmlee 2013 | Mechanism-based pharmacodynamic modeling">Felmlee 2013 | Mechanism-based pharmacodynamic modeling<i class="fas fa-angle-right fa-fw"></i></a></div></div><div id=comments><div id=utterances></div><noscript>Please enable JavaScript to view the comments powered by <a href=https://utteranc.es/>Utterances</a>.</noscript></div></article></div></main><footer class=footer><div class=footer-container><div class=footer-line>Powered by <a href=https://gohugo.io/ target=_blank rel="noopener noreferrer" title="Hugo 0.80.0">Hugo</a> | Theme - <a href=https://github.com/sunt-programator/CodeIT target=_blank rel="noopener noreferrer" title="CodeIT 0.2.10"><i class="fas fa-laptop-code fa-fw"></i>CodeIT</a></div><div class=footer-line><i class="far fa-copyright fa-fw"></i><span itemprop=copyrightYear>2020 - 2021</span><span class=author itemprop=copyrightHolder>&nbsp;<a href=https://sosiristseng.github.io/ target=_blank rel="noopener noreferrer">Wen-Wei Tseng</a></span>&nbsp;|&nbsp;<span class=license><a rel="license external nofollow noopener noreferrer" href=https://creativecommons.org/licenses/by-nc/4.0/ target=_blank>CC BY-NC 4.0</a></span></div></div></footer></div><div id=fixed-buttons><a href=# id=back-to-top class=fixed-button title="Back to Top"><i class="fas fa-arrow-up fa-fw"></i></a><a href=# id=view-comments class=fixed-button title="View Comments"><i class="fas fa-comment fa-fw"></i></a></div><script type=text/javascript src=https://cdn.jsdelivr.net/npm/smooth-scroll@16.1.3/dist/smooth-scroll.min.js></script><script type=text/javascript src=https://cdn.jsdelivr.net/npm/autocomplete.js@0.37.1/dist/autocomplete.min.js></script><script type=text/javascript src=https://cdn.jsdelivr.net/npm/lunr@2.3.8/lunr.min.js></script><script type=text/javascript src=https://cdn.jsdelivr.net/npm/lazysizes@5.2.2/lazysizes.min.js></script><script type=text/javascript src=https://cdn.jsdelivr.net/npm/clipboard@2.0.6/dist/clipboard.min.js></script><script type=text/javascript src=https://cdn.jsdelivr.net/npm/sharer.js@0.4.0/sharer.min.js></script><script type=text/javascript>window.config={"code":{"copyTitle":"Copy to clipboard","maxShownLines":14},"comment":{"utterances":{"darkTheme":"github-dark","issueTerm":"pathname","label":"ðŸ’¬ comments","lightTheme":"github-light","repo":"sosiristseng/sosiristseng.github.io"}},"search":{"highlightTag":"em","lunrIndexURL":"/index.json","maxResultLength":10,"noResultsFound":"No results found","snippetLength":30,"type":"lunr"}};</script><script type=text/javascript src=/js/theme.min.js></script></body></html>